The Food and Drug Administration (FDA) has announced changes to a previous notice about a joint meeting involving the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee. These changes involve updates to the meeting's dates, addresses, and procedures. The meeting is now scheduled for May 5, 2025, from 8 a.m. to 5 p.m. Eastern Time, and public comments will be accepted until the day before. The purpose of the meeting remains to discuss issues regarding extended-release/long-acting opioid analgesic postmarketing requirements.
Simple Explanation
The FDA is having a meeting to talk about rules for certain pain medicines, but they've changed the time and place. People can let them know their thoughts until the day before the meeting happens.